Moreover, we find in this study that sevelamer administration leads to a significant improvement in peripheral insulin sensitivity in non-diabetic subjects with obesity, as measured using insulin clamping, the gold standard for quantitating insulin sensitivity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.